Print
PDF

 

Barts Cancer Institute at Charterhouse Square
Spring/Summer 2012 Seminar Programme
All seminars will take place at 12.30pm unless otherwise stated.
Please see the information box on the right for venue and contact information.
DATE SPEAKER TITLE

29-March

Dr Daniel Foxler
Centre for Molecular Oncology
Barts Cancer Institute, QMUL

Dr Maryam Jangani
Centre for Haemato Oncology 
Barts Cancer Institute, QMUL

‘The tumour suppressor LIMD1 is a regulator of HIF1α and the hypoxic response.’

 

Metastasis related methyltransferase-1 (Merm1) / WBSCR22 Regulates Glucocorticoid Receptor (GR) Function.

Easter Break

19-April

Prof Pascal Meier
The Institute of Cancer
Research

IAP-mediated regulation of cell survival and cancer.

26-April

Dr Paul Boutros
Ontario Institute for Cancer Research

Next-generation sequencing to discover prognostic markers for prostate cancer algorithms and candidates.

03-May

Dr Andrea Kranz
Biotechnology Centre TU
Dresden 

Developmental biology of H3K4 methylation.

10-May

Dr Paul Greaves
Centre for Hamato-Oncology
Barts Cancer Institute, QMUL

Dr Mark Ferguson
Centre for Molecular Oncology
Barts Cancer Institute, QMUL

TBA



Enhancement of systemic delivery of oncolytic Vaccinia virus for the treatment of cancer.

17-May

TBA 

 

24-May

Ms Luisa Robbez-Masson
Centre for Tumour Biology
Barts Cancer Institute, QMUL

Dr Carin Ingemarsdotter
Centre for Molecular Oncology
Barts Cancer Institute, QMUL

Investigating the functional significance of FGFR2 SNP status in Breast Cancer.

 

Coxsackie and adenovirus receptor (CAR) and acquired paclitaxel resistance in ovarian cancer.

31-May

Dr Isabel Jaco
The Institute of Cancer
Research

"PARylation in health and disease"

07-June

Dr Facundo Batista
Cancer Research UK LRI

Dynamic imaging of lymphocyte activation - from single molecule to living tissue.

14-June

Ms Muge Sarper
Centre for Tumour Biology
Barts Cancer Institute, QMUL

MMP-8 expression contributes to altered myoepithelial cell function in DCIS.

21-June

Ms Katrina Sweeney
Centre for Molecular Oncology
Barts Cancer Institute, QMUL

Dr Pedro Maria Casado-Izquierdo
Centre for Cell Signalling
Barts Cancer Institute, QMUL

TBA



Systematic profiling of protein kinase pathway activities in AML cells.

28-June

Prof Henning Walczak
Department of Medicine
Imperial College London 

"Death Receptors and Ubiquitin in Cell Death, Cancer and Inflammation."